The Future of Mental Wellness
Treatments
Evidence-based treatments on the forefront of mental health and pain condition management.
Nationwide
Ten clinics currently open and nine clinic options. Currently have 62,000 square feet of facility space.
Visits
Patient visits at all clinics nationwide are projected to hit 18,000 in 2022 and reach 98,000 by 2025.
Experience
Comprised of clinicians, operators, and marketers with over 90+ years of combined experience.
Introducing Revitalist
The Breakthrough Treatments of Revitalist
- IV Ketamine Infusions
- Ketamine-Assisted Psychotherapy
- Spravato - Esketamine
- Intensive Outpatient Programs
- Medication Infusions
- Vitamin Infusions
Revitalist Annual Patient Visits
- 2021 saw 5,000 visits achieved with seven clinics. Six of the clinics were new and operated on average for 35% of year.
- 2022 projects 18,000 visits, based on ten clinics operating for the full year, achieving gains from maturing in each market, additional marketing initiatives and productivity efficiencies.
- Year-to-date patient visits as of December 31, 2022, 18,562 total visits.
- 2023 projects 30,000 patient visits, based on ten clinics operating for the full year.
The Revitalist Solution
Current Options
Revitalist Solution
Depression
Doctors use antidepressants, but up to two thirds aren’t helped by the first medication. Up to a third are ineffective after several attempts at medication.
Depression
Low-dose ketamine infusions coupled with comprehensive treatment has shown to be over 70% effective for clients with treatment-resistant conditions.
Pain
The medical community is always searching for new pain management options that provide sustained relief without utilizing opioids.
Pain
Revitalist provides treatment in-house, and the effectiveness of ketamine infusions at managing chronic pain oftentimes allows clients to completely wean off current pain medications in collaborations with their providers.
Suicidal Ideation
Current treatments for suicidal ideation include inpatient hospitalization, psychotherapy, and/or antidepressant medications, which take 4-6 weeks to even begin working and oftentimes prove ineffective.
Suicidal Ideation
Repeated low-dose ketamine infusions over a 2-3 week period have been shown to be 70% effective in alleviating suicidal ideations in those suffering from treatment-resistant depression.
Mental Health
1 in 5 U.S. adults live with mental illness. Estimates by the National Institutes of Mental Health suggest that only half of these people receive treatment.
Mental Health
Revitalist wants to increase access to quality mental health and pain management options across the country to allow higher quality of life.
What Our Clients Are Saying
Our Wellness Articles
VANCOUVER, BC, August 24, 2021 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (CSNX: CALM.CN) is pleased to announce that the Company’s subordinate voting shares (“Common Shares”) have been approved for listing on the Canadian Securities Exchange (“CSE”). The Company’s shares will commence trading at market open on August 24, 2021, […]
Kathryn Walker began working in the hospital system in 2003, and left the inpatient sector in 2018 to open Revitalist — one of the first female lead outpatient wellness clinics in Tennessee. “It has been a really amazing adventure so far,” said Walker, who serves as Revitalist’s CEO. “Being a female in this space is […]
Revitalist Lifestyle and Wellness Provides Update on Clinic Operations and Innovative Service Offerings VANCOUVER, BC, August 31, 2021 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (CSNX: CALM.CN) is pleased to provide a comprehensive update on its clinic operations and expansion plans. “Revitalist was founded in 2018 with a single clinic […]
The Future Of Mental Wellness
The Revitalist Provider Portal allows your doctor to easily, and with much attention to privacy, refer you for consultation. Should you receive treatment, we will communicate with your existing provider(s) regarding your care.
More than 70% of patients with treatment-resistant depression (including bipolar patients) experience rapid relief after a low-dose ketamine infusion. Similar success rates have been seen in returning combat veterans suffering from PTSD.
